Hello, everyone, and how are you today? We are just fine, thank you, especially now that the Pharmalot campus has quieted down. The short person has long since left for the local schoolhouse and the official mascots have found comfy places to indulge their snoozing. As for us, we are busy foraging, as usual, for interesting items to pass along. On that note, here are some tidbits to help you get going. Hope your day is a successful one and you conquer the world. And of course, do keep in touch. We cherish your notes and calls …
AstraZeneca filed a lawsuit in a London court against a former executive, Luke Miels, for allegedly violating his employment agreement four months after he was hired by GlaxoSmithKline to run its pharmaceuticals business, Bloomberg News says. Last month, Glaxo said talks were under way to get Miels on board and hoped to reach a resolution soon. Miels was AstraZeneca’s executive vice president for Europe and is now on gardening leave (really?).
Pfizer agreed to settle a lawsuit with the state of Louisiana in which the drug maker will give the state the equivalent of $1 million worth of naloxone doses, which offsets the effects of opioids, according to The Advertiser. Louisiana Attorney General Jeff Landry says the doses, which amounts to about 60,000 vials, will be distributed to first-responders in the state through vouchers.
Selective bias. No one raised a “stink” when Williams and Williams Pharmaceuticals used a paid actor to promote their drug for inappropriate flatulence.
Comments are closed.